Should Western Midstream’s 7.5% Solitude Pipeline Stake Reshape WES Investors’ Long‑Haul Infrastructure Thesis?

وسترن ميدستريم بارتنرز، إل بي

Western Midstream Partners, LP

WES

0.00

  • In August 2026, WhiteWater announced that it, together with Devon Energy, MPLX, Diamondback Energy, and Western Midstream Partners, reached a Final Investment Decision through their Solitude Pipeline System joint venture to build two 48-inch natural gas pipelines from the Permian Basin to Katy, Texas, targeting an initial 2.25 Bcf/d of capacity in the second half of 2029.
  • A key implication for Western Midstream Partners is its 7.5% equity stake in a long-haul, contract-backed pipeline system designed with phased capacity additions and timing flexibility, potentially reinforcing its role in connecting Permian gas supply with growing Gulf Coast demand centers.
  • Now we will examine how Western Midstream’s 7.5% stake in the long-haul Solitude pipeline alters its existing infrastructure-led investment narrative.

The future of work is here. Discover the 38 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Western Midstream Partners Investment Narrative Recap

To own Western Midstream Partners, you need to be comfortable with a capital intensive midstream model that leans on long term, fee based contracts and steady Permian throughput. The Solitude Pipeline JV adds another large project to the queue, but its 7.5% stake and contracted, phased design do not materially change the near term focus on executing Pathfinder, North Loving II and managing balance sheet risk tied to future funding needs.

The recent Solitude announcement fits alongside Western Midstream’s mid 2026 operating and financial results, where higher throughput and revenue showed how existing assets are already being used. Together, they frame a story where nearer dated projects like Pathfinder and North Loving II remain the key volume and cash flow milestones, while Solitude extends that infrastructure led theme further out and modestly increases long term project execution and capital allocation risk.

Yet investors should also be aware of how additional long haul commitments could compound the existing risk that large capital projects might...

Western Midstream Partners' narrative projects $5.2 billion revenue and $1.9 billion earnings by 2029. This requires 6.3% yearly revenue growth and about a $0.6 billion earnings increase from $1.3 billion today.

Uncover how Western Midstream Partners' forecasts yield a $47.08 fair value, a 3% downside to its current price.

Exploring Other Perspectives

WES 1-Year Stock Price Chart
WES 1-Year Stock Price Chart

Simply Wall St Community members have only two fair value estimates for Western Midstream Partners, ranging from about US$47 to US$119, underscoring how far views can stretch. When you set those figures against Western Midstream’s growing pipeline of large projects and the risk that heavy capital spending may weigh on future returns if producer activity softens, it becomes even more important to compare several viewpoints before forming your own expectations.

Explore 2 other fair value estimates on Western Midstream Partners - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Western Midstream Partners research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Western Midstream Partners research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Western Midstream Partners' overall financial health at a glance.

Want Some Alternatives?

Our top stock finds are flying under the radar-for now. Get in early:

  • AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • We've uncovered the 11 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
  • Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.